Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
Publications search results
TitlePublishedTypeProducts
Enhancing carbon acid pKa prediction by augmentation of sparse experimental datasets with accurate AIBL (QM) derived valuesZeneth
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Risk - SOT 2021 Presentation Slidespdf fileKaptisDerek Nexus
Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and postmarketing reports
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Risk - PETA Science Consortium Webinar Slidespdf fileKaptis
The eTRANSAFE Project on Translational Safety Assessment through Integrative Knowledge Management: Achievements and PerspectiveseTRANSAFE
Case study on the use of integrated approaches to testing and assessment for the prediction of a 90-day repeated dose toxicity study (OECD 408) for 2-Ethylbutyric acid using a read-across approach from other branched carboxylic acids.
Guidelines for FAIR sharing of preclinical safety and off-target pharmacology dataeTRANSAFE
2021 Webinar - An overview of Effiris 2.1; An enhanced qualitative model suite for anticipating and mitigating adverse drug reactions – Slides and recordingpdf fileEffiris
Bringing Together Scientific Disciplines for Collaborative Undertakings: A Vision for Advancing the Adverse Outcome Pathway Frameworkpdf fileKaptis
Utilisation of parametric methods to improve percentile-based estimates for the carcinogenic potency of nitrosaminesLhasa Carcinogenicity Database
Deriving compound-specific exposure limits for chemicals used in pharmaceutical synthesis: Challenges in expert decision-making exemplified through a case study-based workshopAI/PDE Data Sharing Project
Beyond adverse outcome pathways: making toxicity predictions from event networks, SAR models, data and knowledgeKaptis
Nexus ICH M7 Expert Review Support Functionality (an infographic)pdf fileDerek NexusSarah Nexus
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Riskpdf fileKaptis
HuskinDB, a database for skin permeation of xenobiotics
2020 AI/PDE Webinar -Acceptable Intake (AI) and Permitted Daily Exposure (PDE) data sharing project for pharmaceutical impurities - Slidespdf fileAI/PDE Data Sharing Project
2020 AI/PDE Webinar -Acceptable Intake (AI) and Permitted Daily Exposure (PDE) data sharing project for pharmaceutical impurities - RecordingAI/PDE Data Sharing Project
Application of adverse outcome pathways (AOPs) to support genotoxicity assessmentpdf fileKaptis
2020 Zeneth 8 webinar - Zeneth 8: A re-designed and improved forced degradation prediction system for organic compounds - RecordingZeneth
2020 Zeneth 8 webinar - Zeneth 8: A re-designed and improved forced degradation prediction system for organic compounds - Slidespdf fileZeneth
Aromatic Amines Database 2020.1.0 Release Notespdf fileAromatic Amines
Setaria 3.3 Installation Guidepdf fileSetaria
Setaria 3.3 Release Notespdf fileSetaria
Elemental Impurities 2020.1.0 Release Notespdf fileElemental Impurities
Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updatesDerek NexusSarah NexusVitic

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.